As the cost of NHS medicines rise, it is important to maintain partnerships between the prescriber, the pharmacist, and the care home to improve compliance to medicines within care homes, says Ian Bell, UK sales country manager, Robotik Technology UK.
In the past 10 years there has been significant growth in the overall number of prescription items dispensed in the community in England – up by 234.1 million items since 2009 to 1.12 billion in 2019.
In 2019, the bill for non-hospital drugs in England was £9.08 billion – an increase of £580 million in a decade.
It is well supported that medical compliance is important for event-free survival. A study found that in post myocardial infarction, there was a significant decrease in the likelihood of a further major vascular event in patients that were greater than 80 per cent compliant compared to non- or less compliant patients.
There are many reasons for non-compliance:
- Patient factors
- Medication factors
- Care provider factors
- Healthcare system factors
Partnerships between these factors are crucial to increase compliance and avoid consequences such as decreased therapeutic benefits for the patient, frequent hospital visits, increased healthcare expenditure, and even overtreatment of a condition.
The story is covered in depth in our July/August issue here.